Qualitative Study of Factors Affecting Patient, Caregiver and Physician Preferences for Treatment of Myeloma and Indolent Lymphoma

Source: Patient Preference and Adherence - Category: International Medicine & Public Health Tags: Patient Preference and Adherence Source Type: research

Related Links:

Publication date: Available online 6 March 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Menelaos Papoutselis, Emmanouil Spanoudakis
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Conditions:   Myeloma;   Lymphoma;   Autologous Transplant Intervention:   Other: Adapted Physical Activity Sponsor:   Weprom Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Abstract Hematologic B-cell malignancies, which have varying behavior patterns, disease processes, and treatment responses, include non-Hodgkin lymphoma, leukemias, and myeloma. Although monoclonal antibodies and other agents have led to dramatic advances in the treatment of B-cell malignancies, the development of small molecules have enhanced the ability to treat and manage these malignancies and their adverse events (AEs). Oncology nurses need to be educated on the unique side effects for each class of these agents so that they can administer interventions to prevent and manage AEs in patients. PMID: 321960...
Source: Clinical Journal of Oncology Nursing - Category: Nursing Authors: Tags: Clin J Oncol Nurs Source Type: research
Publication date: Available online 20 March 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Yasuhiro Tsukamoto, Junichi Kiyasu, Ilseung Choi, Mitsuo Kozuru, Naokuni Uike, Hayato Utsunomiya, Akie Hirata, Eriko Fujioka, Hirofumi Ohno, Eriko Nakashima, Yasuhiro Nakashima, Kaname Miyashita, Yoshimichi Tachikawa, Taisuke Narazaki, Mariko Tsuda, Shojiro Haji, Akiko Takamatsu, Emi Tanaka, Tatsuro Goto, Hiroshi Takatsuki
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Publication date: Available online 20 March 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): David Sallman, John Barnard, Najla H. Al Ali, Guillermo Garcia-Manero, Mikkael A. Sekeres, Amy DeZern, David P. Steensma, Gail Roboz, Elias Jabbour, Jaroslaw P. Maciejewski, Sherry Pierce, Eric Padron, Jeffrey E. Lancet, Hagop Kantarjian, Alan F. List, Rami S. Komrokji
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Publication date: Available online 20 March 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Filomena Emanuela Laddaga, Tommasina Perrone, Marco Moschetta, Sebastio Perrini, Paolo Colonna, Giuseppe Ingravallo, Dario D’abbicco, Giorgina Specchia, Francesco Gaudio
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Publication date: Available online 20 March 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Asmaa Mohsen, Mona Taalab, Nashawa Abousamra, Mohamed Mabed
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Publication date: Available online 20 March 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Bruce D. Cheson, Franck Morschhauser, Peter Martin
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Evaluation of the impact of baseline absolute lymphocyte count (ALC), absolute monocyte count (AMC) and the lymphocyte/monocyte ratio (LMR), on the treatment response and prognosis in 100 Follicular lymphoma (FL) patients were presented. The study showed that ALC, AMC and LMR at diagnosis are simple indices, which reflect the host systemic immunity and can predict the clinical outcomes in FL.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Original Study Source Type: research
Publication date: Available online 19 March 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Yuanyuan Yu, Zhongxia Huang, Wanli Hu, Xin Li, Man Shen, Jiajia Zhang, Ran Tang, Shilun Chen, Wenming Chen
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: International Medicine & Public Health | Lymphoma | Myeloma | Study